Literature DB >> 17824829

The genetic basis of thyroid autoimmunity.

Eric M Jacobson1, Yaron Tomer.   

Abstract

Autoimmune thyroid diseases (AITDs), including Graves' disease (GD) and Hashimoto's thyroiditis (HT), are prevalent autoimmune diseases, affecting up to 5% of the general population. AITDs arise due to interplay between environmental and genetic factors. In the past decade, significant progress has been made in our understanding of the genetic contribution to the etiology of AITDs. Excitingly, several AITD susceptibility genes have been identified and characterized. Some of these susceptibility genes are specific to either GD or HT, while others confer susceptibility to both conditions. The first AITD susceptibility gene locus identified was the Human-Leukocyte-Antigen DR (HLA-DR) gene locus. Subsequently, a quintet of non-HLA genes, including the cytotoxic T lymphocyte antigen (CTLA-4), CD40, protein tyrosine phosphatase-22 (PTPN22), thyroglobulin, and thyroid-stimulating hormone receptor (TSHR) gene, has been shown to contribute to the susceptibility to AITDs. Recently, the mechanisms by which these new AITD genes predispose to AITDs have been dissected. In this review, we overview and highlight the recent data on the genes predisposing to AITDs and the putative mechanisms by which they confer susceptibility to disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17824829     DOI: 10.1089/thy.2007.0153

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  48 in total

1.  Diseases as natural kinds.

Authors:  Stefan Dragulinescu
Journal:  Theor Med Bioeth       Date:  2010-10

2.  Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism.

Authors:  Mihaela Stefan; Eric M Jacobson; Amanda K Huber; David A Greenberg; Cheuk Wun Li; Luce Skrabanek; Erlinda Conception; Mohammed Fadlalla; Kenneth Ho; Yaron Tomer
Journal:  J Biol Chem       Date:  2011-07-12       Impact factor: 5.157

Review 3.  Graves orbitopathy: a perspective.

Authors:  Petros Perros; Gerasimos E Krassas
Journal:  Nat Rev Endocrinol       Date:  2009-06       Impact factor: 43.330

4.  Polymorphism of killer cell immunoglobulin-like receptors (KIR) and their HLA ligands in Graves' disease.

Authors:  Romina Dastmalchi; Ali Farazmand; Sina Noshad; Mohamad Mozafari; Mahdi Mahmoudi; Alireza Esteghamati; Aliakbar Amirzargar
Journal:  Mol Biol Rep       Date:  2014-05-23       Impact factor: 2.316

5.  Employing a recombinant HLA-DR3 expression system to dissect major histocompatibility complex II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective.

Authors:  Eric M Jacobson; Heyi Yang; Francesca Menconi; Rong Wang; Roman Osman; Luce Skrabanek; Cheuk Wun Li; Mohammed Fadlalla; Alisha Gandhi; Vijaya Chaturvedi; Eric P Smith; Sandy Schwemberger; Andrew Osterburg; George F Babcock; Yaron Tomer
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

6.  Serendipitous identification of Graves' disease in identical twins with polydipsia.

Authors:  Andrea K Goldyn; Erica A Eugster; Todd D Nebesio
Journal:  J Pediatr Endocrinol Metab       Date:  2010-12       Impact factor: 1.634

7.  No major genes in autoimmune thyroid diseases: complex segregation and epidemiological studies in a large Tunisian pedigree.

Authors:  Noura Bougacha-Elleuch; Saida Ben Arab; Ahmed Rebai; Mouna Mnif; Abdellatif Maalej; Nadia Charfi; Mohamed Ben Lassouad; Jomaa Jouida; Mohamed Abid; Hammadi Ayadi
Journal:  J Genet       Date:  2011-08       Impact factor: 1.166

Review 8.  Role of genetic and non-genetic factors in the etiology of Graves' disease.

Authors:  M Marinò; F Latrofa; F Menconi; L Chiovato; P Vitti
Journal:  J Endocrinol Invest       Date:  2014-11-25       Impact factor: 4.256

Review 9.  Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

10.  Graves hyperthyroidism after stopping immunosuppressive therapy in type 1 diabetic Islet cell recipients with pretransplant TPO autoantibodies.

Authors:  Pieter Gillard; Volkert Huurman; Bart Van der Auwera; Brigitte Decallonne; Kris Poppe; Bart O Roep; Frans Gorus; Chantal Mathieu; Daniel Pipeleers; Bart Keymeulen
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.